| Literature DB >> 25242935 |
Masoumeh Navidinia1, Shahin Najar Peerayeh1, Fatemeh Fallah2, Bita Bakhshi1, Raheleh Sadat Sajadinia3.
Abstract
The aim of this study was to investigate the phylogenetic background and to assess hlyD (involved in the secretion of haemolysin A) and intI1 (encoding a class 1 integrase) in Escherichia coli isolates derived from urinary and fecal specimens. A total of 200 E. coli isolates was collected from patients presenting with urinary tract infection (UTI) during September 2009 to September 2010 and screened for hlyD and intI1 genes by polymerase chain reaction (PCR). Phylogenetic analysis showed that E. coli is composed of four main phylogenetic groups (A, B1, B2 and D) and that uropathogenic E. coli (UPEC) isolates mainly belong to groups B2 (54%) and D (34%) whereas group A (44%) and D (26%) are predominant among commensal E. coli isolates. In this study, hlyD was present in 26% of UPEC and 2% of commensal E. coli isolates. However, hemolytic activity was detected for 42% of UPEC and 6% of commensal E. coli isolates (p < 0.05). intI1 gene was more frequently expressed in UPEC (24%) in comparison with commensal E. coli isolates (12%). Resistance to aztreonam, co-trimoxazole and cefpodoxime were frequently found among UPEC isolates whereas commensal E. coli isolates were commonly resistant to co-trimoxazole, nalidixic acid and cefotaxime. Concluding, a considerable difference between UPEC and commensal E. coli isolates was observed regarding their phylogenetic groups, presence of class 1 integron and hlyD gene, hemolysin activity and resistance pattern. The detection of class 1 integrons and hlyD gene was higher among UPEC compared with commensal E. coli isolates. These findings may contribute for a better understanding of the factors involved in the pathogenesis of UPEC.Entities:
Keywords: Escherichia coli; hlyD; intI1; phylogenetic typing groups; urinary tract infection (UTI)
Mesh:
Substances:
Year: 2014 PMID: 25242935 PMCID: PMC4166276 DOI: 10.1590/s1517-83822014000200019
Source DB: PubMed Journal: Braz J Microbiol ISSN: 1517-8382 Impact factor: 2.476
Antibiotic resistance pattern among phylogenetic groups in Uropathogenic E.coli isolates from children with community acquired UTI.
| Antibiotic | A | B1 | B2 | D | Total |
|---|---|---|---|---|---|
| Augmentin | - | - | 12% | 2% | 14% |
| Cefotaxime | 3% | 2% | 39% | 1% | 45% |
| Co-trimoxazole | - | 1% | 50% | 10% | 61% |
| Imipenem | - | - | - | - | 0% |
| Nitrofurantoin | - | - | 2% | - | 2% |
| Amoxicillin | - | - | 16% | - | 16% |
| Gentamicin | 2% | - | 19% | 1% | 22% |
| Ciprofloxacin | - | - | 7% | 1% | 8% |
| Amikacin | 1% | 1% | 5% | 1% | 8% |
| Ceftazidime | - | - | 12% | - | 12% |
| Cefpodoxime | 2% | 6% | 38% | 2% | 48% |
| Nalidixic acid | - | - | 9% | - | 9% |
| Azteronam | 1% | - | 48% | 29% | 78% |
Antibiotic resistance pattern among phylogenetic groups in commensal E.coli isolates from children with community acquired UTI.
| Antibiotic | A | B1 | B2 | D | Total |
|---|---|---|---|---|---|
| Augmentin | - | - | 7% | 2% | 9% |
| Cefotaxime | 2% | - | 16% | 9% | 27% |
| Co-trimoxazole | 29% | 14% | 16% | 23% | 82% |
| Imipenem | - | - | - | - | 0% |
| Nitrofurantoin | - | - | 6% | 2% | 8% |
| Amoxicillin | 9% | 1% | 8% | 2% | 20% |
| Gentamicin | - | - | 1% | 11% | 12% |
| Ciprofloxacin | 1% | - | 1% | 3% | 5% |
| Amikacin | - | - | 3% | - | 3% |
| Ceftazidime | - | - | 3% | 4% | 7% |
| Cefpodoxime | 2% | 1% | 15% | 1% | 19% |
| Nalidixic acid | - | 2% | 16% | 9% | 27% |
| Azteronam | 1% | 1% | 11% | 6% | 19% |
Phylogenetic groups distribution of UPEC and fecal E.coli strains in patients with UTI.
| Phylogenetic groups | Number of isolates | Cystitis | Pyelonephritis |
|---|---|---|---|
| A | |||
| Commensal | 44% | 20% | 24% |
| UPEC | 8% | 6% | 2% |
| B1 | |||
| Commensal | 14% | 4% | 10% |
| UPEC | 4% | 4% | 0% |
| B2 | |||
| Commensal | 16% | 0% | 16% |
| UPEC | 54% | 4% | 50% |
| D | |||
| Commensal | 26% | 6% | 20% |
| UPEC | 34% | 16% | 18% |